SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-21-009267
Filing Date
2021-02-16
Accepted
2021-02-16 08:31:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G ea135612-sc13ga2patel_akari.htm SC 13G/A 45201
  Complete submission text file 0001213900-21-009267.txt   46657
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Subject) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: SC 13G/A | Act: 34 | File No.: 005-87614 | Film No.: 21632835
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1111 MAIN STREET SUITE 660 VANCOUVER WA 98660
Business Address
Patel Samir Rashmikant (Filed by) CIK: 0001702447 (see all company filings)

Type: SC 13G/A